68Ga-DOTATATE PET/CT is the most sensitive exam to detect well-differentiated neuroendocrine tumors. Since these tumors have a low glucose consumption but high expression of somatostatine receptors (SSTR) on their surface, 68Ga-DOTATATE is superior to 18F-FDG for tumor detection. This new method has replaced the Octreotide scintigraphiy in our clinic, due to a higher sensitivity and an improved localization of the SSTR positive lesion, thanks to the CT component.
On the axial fused images, a focal DOTATATE accumulation in the pancreas can be localized (red arrow), which corresponds to a small neuroendocrine tumor that could not be delineated with the CT. There is also a lymph node metastasis dorsal to the pancreas (yellow arrow).
The following indication is reimbursed by the health insurance:
In the brain, 68Ga-DOTATATE-PET / CT is suitable for the clarification of meningiomas and meningioma recurrences, e.g. before radiation planning.
High tracer uptake in the meningioma
The following indication is reimbursed by the health insurance:
Senior Attending Physician, Vice Director of the Institute, Department of Nuclear Medicine
Attending Physician, Department of Nuclear Medicine
Attending Physician, Department of Nuclear Medicine
Attending Physician with extended responsibilites, Department of Nuclear Medicine
Attending Physician, Department of Nuclear Medicine
Attending Physician with extended responsibilites, Department of Nuclear Medicine
As a patient, you cannot register directly for a consultation. Please have your family doctor, specialist refer you. If you have any questions, please use our contact form.
Simply assign your patient via registration form.
Medical information hotline: 08.00-18.00 o’clock: +41 44 255 15 02